CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 150 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,288,000 | -14.4% | 1,900,000 | +5.6% | 0.84% | -3.3% |
| Q2 2023 | $61,074,000 | -5.7% | 1,800,000 | 0.0% | 0.87% | -7.3% |
| Q1 2023 | $64,764,000 | -19.3% | 1,800,000 | 0.0% | 0.94% | -11.7% |
| Q4 2022 | $80,226,000 | +58.6% | 1,800,000 | 0.0% | 1.06% | +46.7% |
| Q3 2022 | $50,598,000 | +102.9% | 1,800,000 | +94.6% | 0.73% | +105.7% |
| Q2 2022 | $24,938,000 | – | 925,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |